DrugAlert provides timely medication-related advice direct to your inbox.
Scroll

DrugAlert

DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.

Availability of Capecitabine 500mg Tablets

DrugAlert Volume 1016

HPS Pharmacies wish to advise that both suppliers are experiencing a supply interruption for capecitabine 500mg tablets as follows: Xelabine Capecitabine 500mg ARTG 213045  Capecitabine Sandoz Capecitabine 500mg ARTG 201800 This supply interruption is…

Read more

Availability of Zyprexa® IM 10mg

DrugAlert Volume 1015

HPS Pharmacies wish to advise that Pharmaco Australia is experiencing a supply interruption for Zyprexa® IM as follows:   Zyprexa IM® Vial Olanzapine 10mg ARTG 76867   This supply interruption is expected to be…

Read more

Availability of Prazosin Tablets

DrugAlert Volume 1014

HPS Pharmacies wish to advise that all suppliers are experiencing a supply interruption for prazosin 1mg and 2mg tablets, as follows: Product ARTG Estimated return date APO-Prazosin 1 mg 73858 End-August 2025 APO-Prazosin 2…

Read more

Constrained supply of Paracetamol Kabi 1g/100mL Vials

DrugAlert Volume 1013

HPS Pharmacies wish to advise that Fresenius Kabi has placed restrictions on the ordering of their paracetamol vials, as follows: Paracetamol Kabi 1g/100mL Vials Paracetamol 1g/100mL ARTG 203624 Fresenius Kabi has advised that stock…

Read more

Discontinuation of Pfizer Sodium Chloride 0.9% IV infusion

DrugAlert Volume 1012

HPS Pharmacies wishes to advise that Pfizer is discontinuing their sodium chloride 100 mL vials as follows: Pfizer Sodium Chloride 0.9% IV infusion Sodium Chloride 900mg/100mL ARTG 49280 Pfizer estimates that wholesale stock will…

Read more

Availability of Ozempic®

DrugAlert Volume 1011

HPS Pharmacies wish to advise that Novo Nordisk has released a new presentation of Ozempic®, as follows: Ozempic® 0.25/0.5mg Pen Semaglutide 0.68 mg/mL, 3 mL ARTG 446290 This new product replaces the Ozempic® 0.25/0.5mg…

Read more
Load More